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ABSTRACT 
 
 The 2016 US Presidential Election was hallmarked by significant policy differences 
between the Democratic and Republican parties. Healthcare reform was one of the most 
significant and highly debated issues between the candidates; Hillary Rodham Clinton (D-NY) 
and Donald J. Trump (R-NY). The Republican platform of repeal and replace was in direct 
opposition to the expansionary viewpoints of the Democratic Party which was to promote 
increased regulations on the healthcare and pharmaceutical industries. The media narrative in 
the months preceding the election assumed a Democratic victory as a sure thing.  The New 
York Times gave Hillary Clinton a 98.5% chance of victory at the beginning of election 
night, making the landslide victory of Donald Trump over Hillary Clinton one of the greatest 
political upsets of the modern political era. In order to determine if market indicators were 
predicting a Republican victory in the election; we analyze financial performance of securities in 
the healthcare sector through standard event study techniques. In particular I use multivariate 
regression to calculate cumulative abnormal returns centered around varying time windows 
surrounding the Presidential Election. Financial data from 402 relevant healthcare firms is used 
in the analysis. Significant cumulative abnormal returns are observed for pharmaceutical/drug 
companies and healthcare companies in the event windows leading up to the election date. 
While negative in longer pre-event windows, returns become sharply positive on the days prior 
to the election. This is particularly true for pharmaceutical firms and healthcare stocks. Despite 
the prediction of Democrat victory in both the polls and in prediction markets, it is possible to 
show that the stock market accurately predicted a Republican victory in the General Election 
despite overwhelming odds indicating a Democrat victory.  
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Event study techniques were replicated in a manner utilized in a similar study 
surrounding the passage of the Affordable Care Act and its approval by the Supreme Court[1]. 
Pre- and post-election analysis of the healthcare sector firms was conducted in a manner to 
analyze the effects of the election on the financial performance of the healthcare related firms[2].  
 
INTRODUCTION 
 
Political Background of Healthcare Debate 
The 2016 Presidential election is widely considered to be the greatest upset in American 
political history with Republican nominee Donald Trump accomplishing a surprise victory over 
the former Secretary of State and Democratic nominee Hillary Clinton. This was preceded by 
President Trump defeating one of the most diverse field of candidates on the Republican 
primary stage in a generation. Election night, November 8, 2016, saw Secretary Clinton with a 
greater than 90% chance of victory according to the Princeton Election Consortium, New York 
Times, and other new agencies that were reporting the election[3]. However, voters turned out in 
mass in key swing states to secure the victory for candidate Trump. This victory, completely out 
of left field, created what we would consider to be a raw and unexpected upset to.  
One of the most controversial and constantly debated political issues of the 2016 
election was the subject of healthcare reform. The average cost of healthcare per individual in 
the US has been increasing for the last half of the 20th century and into the 21st, with per-capita 
spending on healthcare having increased 57 times from the inception of Medicaid to 2010[4]. 
This has prompted an increase in government intervention in the healthcare sector and related 
legislation. The legislation addresses the major issues facing consumers such as: constantly 
increasing healthcare costs, the rising population of uninsured individuals in the US and their 
inability to obtain insurance, and the difficulty of obtaining insurance by person with pre-existing 
conditions. As a result, legislatures proposed and passed the Patient Protection and Affordable 
Care Act, commonly known as the Affordable Care Act (ACA) or ObamaCare, in March 2010[5].  
The ACA was not passed controversy-free or without extreme opposition in Congress 
from the Republican party. Not a single Republican representative in the House or Senate voted 
in favor of the bill[6]. The ACA was the subject of a repeal vote on 56 occasions from its 
inception to the start of the 2016 electoral race when Donald Trump entered the arena in the 
summer of 2015[7]. All Republican candidates for the 2016 race issued promises or held policy 
positions towards a “repeal and replace” approach to the ACA, a sentiment which was echoed 
by virtually all of their colleagues running for positions in Congress.  
With the repeal and replacement of the ACA as a cornerstone of all Republican 
candidates campaigns in regards to healthcare, a vote for the Republican ticket could be 
categorized as a vote for the repeal of the ACA[8].  
 
Democratic Victory A “Sure Thing” and Influences Healthcare Sector 
While Republican candidates were unified in a dissolution of the ACA. The Democratic 
field of candidates, spearheaded by Hillary Clinton, proposed a fundamentally different 
approach to the health care question by maintaining the status quo[10].  
Due to the forecasted victory of the Democratic party in the 2016 election. The financial 
performance of the healthcare sector continued normally as it had done in the 8 years since the 
passage of the ACA[17]. The supposed incoming administration’s healthcare policy direction 
mirrored that of the Obama administration resulting in a ‘business-as-usual’ attitude in the 
markets[9].  
Hillary Clinton took the position which advocated for expansions of coverage offered by 
the ACA and an increase in participation related tax credits. Hillary repeatedly went after 
healthcare and pharmaceutical manufacturers by accusing companies of domestic price 
gouging and calling for increased regulations on pharmaceutical manufacturers [11]. Hillary’s 
campaign position was to pursue implementing higher rebates for prescription drugs through 
Medicare thus opening the way for open negotiations of drug prices[12]. The Democratic platform 
also advocated for the elimination of barriers preventing the importation and use of prescription 
medications and regulate companies that utilized their influence to delay the release and 
distribution of generic drugs[13].  
Hillary’s viewpoints and campaign platform on healthcare was a major contributing factor 
to her election platform; as a result, there were observations of stock price fluctuations based on 
her ‘tough talk’ regarding the pharmaceutical companies and the Democratic Party’s 
antagonistic stance against the healthcare provider field.  
The Democratic Party has continually championed the merits of the ACA and the 
platform of all candidates was to preserve the ACA and secure its continued existence. The 
ACA was passed under a Democrat administration and was the crowning achievement of the 
Obama presidency; most if not all democrats want it to continue unabated.  
 
ACA’s Effect on the Healthcare Firms 
 The continued support of the ACA by the Democratic Party and the negative 
commentary by the Dems regarding pharmaceutical and health insurer companies reflected in 
their financial performances and molded their strategies in Congress[14]. It was noted  
Pharmaceutical and healthcare related firms took an extreme level of interest in the effects the 
ACA would have on their industry. The amount of capital spent on lobby efforts in congress by 
pharmaceutical and healthcare firms increased exponentially from the time of the passage of 
the bill to the present day[15]. This increase in lobbying underlined an environment of uncertainty 
in regards to the effects of the ACA and caused a continual downward trend in abnormal returns 
of the healthcare sector.  
 Scope of Study 
The objective of this study is to determine whether the performance indicators for 
healthcare sector companies were predictive of the surprise election results in 2016 and if those 
trends continued into the post-election period. Results show that, despite late-stage polling and 
even prediction markets that pointed to aCLinton victory, stock returns in the healthcare industry 
turned abnormally positive in the days leading up to the election. This is particularly true for 
pharmaceutical and healthcare stocks. These results indicate that while polls and prediction 
markets were completely taken by surprise on Election night, the equity market for the 
healthcare sector seemed to anticipate a Trump victory 
 
DATA DESCRIPTION 
 
Data Source 
The financial data used in this study was collected from the Center for Research on 
Security Prices (CRSP). Individual firms were selected based on the designation of their 
Standardized Industry Codes(SICs), which are widely used to categorize each firm by type. The 
analysis conducted in this paper was constrained to four different categories of firms: 
drug/pharmaceutical companies, health insurers, healthcare providers, and medical device 
producers. The financial data compiled from these firms was used to execute a series of stand 
event studies surrounding the day after the 2016 Presidential Election results were announced; 
t=0 being designated as November 9, 2016. Due to the unexpected election results, we can 
examine the behavior of the healthcare sector in response to such an unfavorable event to the 
established ACA.  
A total of 402 firms were analyzed with 59 designated as Pharmaceutical/Drug 
companies, 378 firms listed as health care providers, 14 listed as insurers, and 51 listed as 
medical product manufacturers. It should be noted; several of the listed companies fall into one 
or more categories listed above, as a result the results of the event study do not sum to 402.  
 
Summary Statistics November 9, 2016 
Table 1 of the Appendix is a report of summary statistics for the healthcare firms 
sampled in this study on the date of the presidential election November 9th, 2016. Price is the 
closing share price according to CRSP. MktCap is the firm's market capitalization. Turn is the 
share turnover or the daily volume scaled by shares outstanding. Spread is the bid-ask spread 
using closing bid and ask prices from CRSP. Pvolt is a measure of price volatility, which is the 
difference between the daily high price and the daily low price scaled by the daily high price. 
DRUG is an indicator variable equal to one if the firm is classified as a pharmaceutical company 
according to standard industry codes, otherwise it is denoted by a zero. HEALTHCARE is an 
indicator variable capturing healthcare companies. INSURER is an indicator variable capturing 
whether the company is considered a health insurer. DEVICE is an indicator variable equal to 
one if the company is classified as a medical product or manufacturer company. Companies are 
designated to these categories by their standard industry codes (SICs). In this study, 
HEALTHCARE companies made up 94.26% of the sample, DRUG made up 14.93%, DEVICE 
12.72%, and INSURER was the smallest at 3.49%. We note that these percentages to not sum 
to 100%; some firms are identified as two or more types according to their SIC’s. Inasmuch the 
components analyzed in Table 1 do not sum to 402. It should be noted that a limitation of this 
study is that the small sample size of some of our categories, specifically INSURER (N=14), 
DEVICE(N=51), and DRUG (N=59); it may be difficult to determine significant results.   
Table 1 shows that the average firm had a share price (Price) of $34.84 and a market 
capitalization (MktCap) of approximately $7.7 billion. Average share turnover (Turn) on the day 
after the election was 18.625%. The average security’s bid-ask spread was calculated using 
closing ask and bid prices from CRSP[16].  The price volatility (Pvolt) variable is denoted from a 
study from Diether, Lee, and Werner (2009) that the method of computing price volatility as a 
difference between the highest price during a particular day and the lowest price during a 
particular day, scaled by highest price, is better able to capture more volatile stocks.   
 
EMPIRICAL RESULTS AND FINDINGS 
 
To begin our study, we conducted univariate tests wherein we examine the performance 
of our entire sample of healthcare firms using traditional event study methods surrounding our 
t=0 reference of November 9, 2016. This is then followed by a firm specific series of multivariate 
tests to analyze financial performance of the individual company types designated DRUG, 
HEALTHCARE, INSURER, and DEVICE. 
 
Cumulative Abnormal Returns - Industry Wide - Pre-Election 
 Table 2 is a report of mean Cumulative Abnormal Returns (CARs) and Z-statistical tests 
for the entire sample of healthcare companies for various pre-election time window. We 
determined CARs estimations through a daily market model and abnormal returns are defined 
as the residuals from the market model.  
 In Table 2 we report our estimates of mean cumulative abnormal returns of the entire 
sample for the pre-election time windows of [-30 to -1], [-20 to -1], [-10 to -1], [-5 to -1], [-3 to -1], 
and [-1 to 0], where day zero is the day after the election day November 9, 2016. We use the 
day after the election day since this is the first full day after election results were in.  The 
Jackknife Z-statistic, and Patell statistic are also included to assist in determining the overall 
statistical significance of the results. The Patell test is a widely used test statistic determined by 
standardizing the abnormal returns before calculating the test statistic. The Jackknife Z-test is 
used due to its robustness to changes in information flow during a financial event in not 
assuming stationary variance in returns; this gives us a more fluid and accurate representation 
of our distribution of results. The results of the Patell and Jackknife test in Table 2 show that the 
results of the cumulative abnormal returns performing well below the mean return of the market; 
our results show the Z-statistics trending toward the positive in the days preceding the election 
and support the evidenced claim of the market predicting a Trump Election. 
Table 2 reports estimated CARs are statistically significant and are negative in the 
windows leading to the election while trending towards the positive as the election drew closer. 
Trending from -9.83% abnormal returns in the 30-day pre-event period to 1.13% in the previous 
4 days. That’s a shift in a month from a -79.91% to 94.92% in annualized returns. The Patell 
and Jackknife Z tests also display a shift from a negative to positive mean return distribution 
lending evidence to the hypothesis that the market was predictive of a Trump victory with 
upward trending abnormal returns; this is directly contrary to the media narrative that was 
prevalent at the time of the election.  
 
Cumulative Abnormal Returns - by Firm Type - Pre-Election 
 CARs are reported based on company type in Table 3. Like Table 2; mean CARs are 
estimated along with two separate Z-test statistics (Patell [in brackets] and Jackknife [in 
parentheses]) for each of the four types of firms used in the sample, which are categorized by 
their SIC designation. DRUG is designated for any companies that are classified as 
pharmaceutical in column [1], HEALTHCARE in column [2] denotes healthcare companies, 
INSURER in column [3] identifies companies who are health insurers, and DEVICE in column 
[4] identifies medical product manufacturers. Similar to the firm wide event study, our windows 
of observation are the prior 31 days to the event, November 9, 2016 designated with CAR(-1,0), 
CAR(-1,1), CAR(-5,-1), CAR(-10,-1), and CAR(-20,-1) and CAR(-30,-1). These event windows 
are used to obtain estimates of CARs using a daily market model and summing the residual 
returns 
The results of the analysis determine a high level of statistical significance in the period 
before the election among the DRUG, HEALTHCARE, and DEVICE designations. INSURER 
observed significance in the 3 days surrounding the election CAR(-1,1) but not in the month 
preceding the election.  
DRUG and HEALTHCARE companies displayed statistically significant abnormal returns 
throughout the entire event window. It is observed that the CARs steadily peaked from negative 
to positive leading up the election; as will be evidenced in the post-election results. DEVICE 
oriented firms saw significant negative CARs in the 30, 20, and 10 day time windows prior to the 
election but were trending in the positive from -9.55%(CAR(-30,-1)) (-77.63% annualized 
abnormal return) to 0.34% (28.56% annualize abnormal return) in the 3-day period surrounding 
the event (CAR(-1,1)). These positive trends in CARs continued into the post-election time 
windows. The DRUG and HEALTHCARE firms had the greatest to gain from a Republican 
victory in the Presidential Election; with the promise of deregulation coupled with the repeal and 
replace of the ACA. DRUG and HEALTHCARE both saw a sharp increase on the day of the 
event; obviously in reaction to the Republican victor in the election. This is evidenced in 
columns [1] and [2] of Table 3 as mean CARs jumped by 4.03% in HEALTHCARE and 0.71% in 
DRUG in the day after the election.  
The trend of CARs in in DRUG and HEALTHCARE makes a shift from negative to 
positive in the time period of CAR(-3,-1). From CAR(-5,-1) to CAR(-3,-1): DRUG increased from 
-2.94% to 1.33%, HEALTHCARE increased from -1.2% to 1.33%. INSURER dropped its CARs 
in the CAR(-3,-1) period and raised dramatically the day after the election and showed greater 
statistical significance.  
These results coupled with the industry wide analysis in Table 2, indicate that stock  
market for the healthcare industry seemed to accurately predict a victory for Donald Trump days 
before the election ever took place and contrary to polls and all the predictive markets.  
 
  
Cumulative Abnormal Returns - Industry Wide Post-Election 
 The following is a recreation of a previous post-election CAR event study for the 
healthcare sector to coincide with our pre-election results[2]. 
Table 4 is a summary of the Cumulative Abnormal Returns (CARs) for the selected 
event windows on a sector wide view incorporating our entire sample for the post-election time 
windows. As above, also included are the Jackknife and Patell Tests, reported in parentheses 
and brackets respectively in the table. We determine cumulative abnormal returns for a variety 
of post-event time periods where CARs are estimated through a daily market model and 
abnormal returns are defined as the residuals from the market model. 
In Table 4, we report our estimates of cumulative abnormal returns for the 10-day period 
leading up to our event date (CAR(-10,-1)) due to its high statistical significance among all 
company types as explained earlier, the three day period surrounding the event date (CAR(-
1,1)), the two day period immediately following the event date (CAR(0,1)), which is then 
followed by the following 11, 21, and 31 days (CAR(0,10), CAR(0,20), CAR(0,30)).  
The results of the test display statistically significant abnormal returns over a majority of our 
event window and the presidential election. We find that mean CARs are reliably different from 
zero in columns [1] through [5], and not reliably different from zero in column [6]. The results in 
column [1] are negative while [2] through [6] are positive. Column [3] (CAR(0,1)) reports a 
cumulative abnormal return of 3.97% which annualized to a total return of 500.22%. CARs 
remain statistically significant up to 21 days out CAR(0,20). There are no significant CARs 
reported in column [6], the 30-day window of our study.  
Based on the results of our CAR(0,20) and CAR(0,30), we see that as time went on the 
prelection trends of positive CARs continued, but investors began to realize that the repeal of 
the regulation heavy ACA, which was promised by President Trump, would be much more 
difficult to accomplish than initially thought.   
 
Cumulative Abnormal Returns - Firm Specific - Post Election 
Cumulative Abnormal Returns are reported based on company type in Table 5. Similar 
to Table 4; mean CARs are estimated along with two separate Z-test statistics (Patell [in 
brackets] and Jackknife [in parentheses]) for each of the four types of firms used in the sample, 
which are categorized by their SIC designation as in Table 3. Similar to the firm wide event 
study, our windows of observation are the prior 10 days to the event, November 9, 2016 (CAR(-
10,-1)) and similarly with CAR(-1,1), CAR(0,1), CAR(0,10), CAR(0,20), and CAR(0,30). These 
event windows are used in obtained estimates of CAR using a daily market model and summing 
the residual returns.  
The empirical results displayed in the Table 5 display that there is a presence of 
statistically significant cumulative abnormal returns in the DRUG (column [1]), HEALTHCARE 
[2], and INSURER [3] operating companies and none offered in the post-election time window of 
the DEVICE [4] category. This can be viewed as a continuation of the increasing abnormal 
returns from the prelection period and now the market has reacted in full to the results of the 
election.  
DRUG and HEALTHCARE both saw a significant amount of negative abnormal returns 
in the preceding days of the election. However, as explained in the previous sections, trends in 
CARs shifted to positive prior to the election which would indicate a victory for Republicans and 
an outlook forecasting the repeal and replacement of the ACA.  
In examining the time window of the day of the election and the day following (CAR(0,1)) 
that cumulative abnormal returns are significant across all company types except DEVICE. 
DRUG [1] cumulative abnormal return from CAR(-10,-1) is -6.4% or -146.62% CAR(0,1) 7.69% 
annualized to 968.94%. This is a clearly evidenced effect of the surprise election of Donald 
Trump; the industry was in a steady decline leading up the election and then shifted to make a 
massive upturn in the wake of the result, in just a 2-day period. HEALTHCARE stocks saw a 
CAR (-10,-1) of -4.99% (-114.32% annualized) to CAR(0,1) of 3.78% (476.28% annualized). 
INSURER saw statistically significant CAR(0,1) of 1.95% (245.70% annualized). 
HEALTHCARE, representative of the industry as a whole with its significant sample size, loses 
its significance after CAR(0,10) or 11 days from the event while the smaller DRUG [1] and 
INSURER stocks hold significance 21 and 31 days out respectively DRUG [1] CAR(0,30) 
annualizes to 29.508% and INSURER CAR(0,30) annualizes to 46.905%. While DRUG 
designated companies display much larger cumulative abnormal returns in the early days of the 
study and after the election, INSURER designated companies report the larger abnormal 
returns and statistical significance in the longer term 31-day window. This may be indicative that 
insurance designated companies may continue to exhibit continued abnormal returns into the 
future.  
 
CONCLUSIONS AND INTERPRETATION OF FINDINGS 
 
 The implications of the performance of healthcare sector firms leading up to the US 
Presidential Election, especially in the pharmaceutical and healthcare provider industries, have 
shown that they are capable of accurately predicting the results of the election. The statistical 
significance in our tested time windows leading up to the election accurately show that the 
tested HEALTHCARE firms is the greatest indicator regarding the healthcare sector. The 
continually upward trending abnormal returns accurately predicted an impending policy shift in 
Washington. This finding is supported by the continually upward trending, statistically significant, 
pre-election abnormal returns for the HEALTHCARE, DRUG, and INSURER companies. It is 
further supported by the shift in CARs from negative to positive occurring before the election 
took place, mostly evidenced in CAR(-3,-1) of Table 3.  
 The result of this analysis showcase the market as predicative indicator in regards to 
impending policy shifts in Washington. The completely opposite party platforms related to 
healthcare may have also sharpened the accuracy of the predictions as well.  
  
APPENDIX & TABLES 
 
        
Table 1       
SUMMARY STATISTICS OF SAMPLED HEALTHCARE STOCKS - NOVEMBER 9TH 2016  
 Mean Median 
Std. 
Deviation Min Max  
 [1] [2] [3] [4] [5]  
       
Price 34.84 12.7 60.2209 0.0515 651.46  
MtkCap $7.7M $472,223.77 $26.79M 2290.61 $329.15M  
Turn 18.6245 11.0858 26.1708 0.0484 297.9262  
Spread 0.0673 0.0100 0.4390 0.0001 7.8999  
Pvolt 0.0774 0.0686 0.0436 0.0000 0.3120  
DRUG 0.1493 0.0000 0.3543 0.0000 1.0000  
HEALTHCARE 0.9426 1.0000 0.0233 0.0000 1.0000  
INSURER 0.0349 0.0000 0.1838 0.0000 1.0000  
DEVICE 0.1272 0.0000 0.3336 0.0000 1.0000  
       
 
 
Table 2       
Pre 2016 Election- Full Sample - Full Sample Statistical Significance 
 CAR(-30,-1) CAR(-20,-1) CAR(-10,-1) CAR(-5,-1) CAR(-3,-1) CAR(-1,0) 
       
Mean -0.0983*** -0.0869*** -0.0495*** -0.0135 0.0113*** 0.0201*** 
Median -0.0848 -0.0672 -0.0324 -0.005 0.012 -0.02 
       
Jackknife 
Z -12.187 -14 -8.405 -0.599 -5.263 -7.49 
Patell Z -12.654 -12.872 -9.593 -0.875 5.850 9.727 
Statistical significance at the 0.10, 0.05, and 0.01 level are denoted by *, **, and *** respectively. 
 
 
 
 
 
 
 
       
Table 3         
CAR Results by Firm Type - Pre-Election Results  
 DRUG  HEALTHCARE  INSURER  DEVICE  
 (N=59)  (N=378)  (N=14)  (N=51)  
 [1]  [2]  [3]  [4]  
 
       
 
CAR(-30,-1) -0.0857***  -0.1050***  0.0198  -0.0955***  
 [-3.858] 
 [-11.375]  [1.031]  [-5.125]  
 (-3.578) 
 (-11.512)  (1.182)  (-3.995)  
 
       
 
CAR(-20,-1) -0.1073***  -0.0914***  0.0195  -0.0592**  
 [-5.354] 
 [-11.353]  [1.105]  [-4.295]  
 (-5.513) 
 (-12.594)  (1.330)  (-4.555)  
 
       
 
CAR(-10,-1) -0.064***  -0.0499***  0.0124  -0.0462**  
 [-4.062] 
 [-8.157]  [1.163]  [-3.774]  
 (-3.779) 
 (-7.49)  (1.355)  (-2.538)  
 
       
 
CAR(-5,-1) -0.0294  -0.012  0.0342  -0.0185  
 [-2.008] 
 [-0.783]  [3.355]  [-0.212]  
 (-1.074) 
 (-0.735)  (2.655)  (-0.091)  
 
       
 
CAR(-3,-1) 0.0133*  0.0133***  0.0287  -0.011  
 [1.741] 
 [5.360]  [3.301]  [0.158]  
 (1.980) 
 (4.824)  (2.231)  (0.251)  
         
CAR(-1,0) 0.0516***  0.0206***  0.0003  -0.0143  
 [8.665] 
 [8.593]  [1.131]  [-2.789]  
 (6.078) 
 (6.691)  (0.715)  (-1.400)  
 
       
 
CAR(-1,1) 0.0729***  0.0368***  0.0277***  0.0034  
 [9.488]  [12.114]  [4.404]  [-0.321]  
 (7.251)  (8.969)  (2.322)  (0.575)  
Statistical significance at the 0.10, 0.05, and 0.01 levels is designated with *, **, and *** 
respectively 
Z-Statistics reported in Parentheses (Jackknife) and Brackets [Patell] respectively. 
        
 
 
 
       
        
Table 4       
Post 2016 Presidential Election  - Full Sample Statistical Significance 
 CAR(-10,-1) CAR(-1,1) CAR(0,1) CAR(0,10) CAR(0,20) CAR(0,30) 
 [1] [2] [3] [4] [5] [6] 
       
Mean -0.0495*** 0.0374*** 0.0397*** 0.0443*** 0.0187** 0.0006 
Median -0.0324 0.036 0.0375 0.0361 0.0098 -0.004 
       
Jackknife 
Z -8.405 10.616 11.078 7.147 1.636 -0.625 
Patell Z -9.593 14.403 17.945 7.03 1.033 -0.4 
Statistical significance at the 0.10, 0.05, and 0.01 level are denoted by *, **, and *** respectively. 
        
  
        
Table 5        
CAR Results by Firm Type - Post Election 
Results     
 DRUG  HEALTHCARE  INSURER  DEVICE 
 (N=59)  (N=378)  (N=14)  (N=51) 
 [1]  [2]  [3]  [4] 
        
CAR(-10,-1) -0.064***  -0.0499***  0.0124  -0.0462** 
 [-4.062]  [-8.157]  [1.163]  [-3.774] 
 (-3.779)  (-7.49)  (1.355)  (-2.538) 
        
CAR(-1,1) 0.0729***  0.0368***  0.0277***  0.0034 
 [9.488]  [12.114]  [4.404]  [-0.321] 
 (7.251)  (8.969)  (2.322)  (0.575) 
        
CAR(0,1) 0.0769***  0.0378***  0.0195**  0.016 
 [11.951]  [14.869]  [4.097]  [0.908] 
 (8.172)  (9.200)  (1.88)  (1.326) 
        
CAR(0,10) 0.0808***  0.0390***  0.065***  0.0354 
 [4.965]  [4.976]  [4.352]  [0.599] 
 (6.038)  (5.349)  (3.259)  (1.147) 
        
CAR(0,20) 0.0608***  .0083  0.0713***  0.0323 
 [2.241]  [-0.358]  [3.490]  [-0.049] 
 (2.680)  (0.304)  (3.818)  (0.298) 
        
CAR(0,30) 0.0363  -0.0071  0.0577***  0.0006 
 [1.237]  [-0.994]  [2.255]  [-0.868] 
 (1.277)  (-1.218)  (3.008)  (-0.772) 
Statistical significance at the 0.10, 0.05, and 0.01 levels is designated with *, **, 
and *** respectively 
Z-Statistics reported in Parentheses (Jackknife) and Brackets 
[Patell] respectively.  
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